Multiwell In Vitro Assay System for Anti-Cancer Agent Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional drug development methods often fail to account for the microenvironment in which cells operate, leading to promising drug candidates failing in clinical trials due to their effectiveness being misjudged in isolated in vitro studies.
Innovation Solution
An in vitro assay system that simulates the liver and kidney's drug clearance and bone marrow toxicity, using a multiwell plate setup with a removable insert containing tumor cells and stromal support cells, to assess anti-cancer agents' viability and toxicity in a more realistic biological context.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional in vitro screening methods are used to identify anti-cancer agents, then high-throughput screening efficiency is improved, but the reliability of predicting in vivo efficacy deteriorates
Solution Approach 1:
The assay system is segmented into distinct functional components: a first well containing liver-derived layer and bone marrow cells to assess drug clearance and toxicity, and a second well containing tumor cells to assess anti-cancer activity. This segmentation allows simultaneous evaluation of multiple parameters that collectively improve in vivo efficacy prediction while maintaining high-throughput capabilities.
Solution Approach 2:
The patent introduces an intermediary in vitro assay system that includes liver-derived layers and bone marrow cells as mediators to bridge the gap between simple in vitro screening and complex in vivo testing. These intermediary components simulate in vivo physiological processes, providing a more reliable prediction of clinical efficacy without sacrificing screening throughput.
2Ease of operation
If isolated cell culture systems are used, then ease of operation is improved, but the accuracy of mimicking in vivo microenvironment deteriorates
Solution Approach 1:
The complex in vivo microenvironment is segmented into discrete, manageable cell layers and components that can be individually cultured and then assembled in a controlled in vitro system. This includes separate liver-derived layers, bone marrow cell layers, and tumor cell layers, each maintaining its specific physiological characteristics while being operable in standard laboratory conditions.
Solution Approach 2:
The system employs parameter changes in cell density, layer thickness, and co-culture ratios to accurately mimic in vivo microenvironmental conditions. By adjusting these parameters, the assay maintains ease of operation while achieving high fidelity representation of physiological interactions between different cell types.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This system effectively filters out candidates that are inactivated by liver enzymes, non-toxic to bone marrow cells, and retain anti-cancer activity, reducing the need for futile animal experiments by mimicking in vivo conditions.
Implementation Method 1
a lower surface comprising a semi-permeable membrane
Implementation Method 2
a lower surface comprising a semi-permeable membrane
Data Source
AI summary
The present disclosure relates generally to drug discovery and development and, more particularly, to in vitro assay systems and methods for selecting lead anti-cancer agents for subsequent testing in human and non-human subjects. The present disclosure allows filtering for candidate anti-cancer agents that are not inactivated by liver enzymes, are able to diffuse through cell layers, are not toxic to bone marrow cells, retain anti-cancer activity in the context of stromal support, and are effective after time-limited exposure mimicking non-hepatic clearance by kidneys and other mechanisms.